Scholars Central

Conference abstractPublished 2018

Pancreatic cancer: radical surgery as a part of multimodal treatment

Authors: Ryska M, Nikov A

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Pancreatic cancer is solid malignant, chemoresistant tumour with unfavourable prognosis. Radical resection with adjuvant chemotherapy is only potential curable therapeutic modality enabling to prolong survival of 25% patients. Borderline conception contents active approach to primary non-resectable patients to reach resectability by neoadjuvant chemo (radio) therapy. Palliative and symptomatic therapy is indicated in about 70 % patients. In the case of suspicious of pancreatic cancer, patient should be referral to specialized centre. Effective diagnostic therapeutic approach only guarantees optimal quality of life of these patients.

Subjects

Surgery

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Universal Surgery.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Universal Surgery
  • SubjectSurgery
  • BylineArticles whose byline prints “Ryska M”
  • BylineArticles whose byline prints “Nikov A”